宋莉,颜红兵,王健,赵汉军,李庆祥,吴铮,迟云鹏,李世英,徐方兴

• 1:首都医科大学附属安贞医院心内科28病房

摘要(Abstract)：

目的了解急性心肌梗死(AMI)治疗中主动脉内球囊反搏术(IABP)的应用、并发症发生率和对近期预后的影响。方法单中心注册研究。连续入选2004年10月至2008年7月间,就诊于北京安贞医院28病房置入IABP的所有AMI患者。结果806例AMI患者中,共有121例(15.0%)置入IABP。最常见指征为高危冠状动脉(冠脉)造影和(或)PCI术中和术后提供血流动力学支持(66.9%)和心源性休克(26.4%)。IABP置入成功率为98.3%,平均使用时间为34±16h。严重并发症发生率为0%。所有患者均进行了冠脉造影,93.4%在出院前施行了冠脉血管重建。总住院死亡率为13.2%(其中心源性休克患者34.4%),住院死亡率因置入IABP指征不同和施行冠脉血管重建与否存在很大差异。结论IABP可成功应用于AMI的多种高危状况并提供必要的血流动力学支持,严重并发症罕见,联合冠脉血管重建治疗可降低死亡率。

关键词(KeyWords)： 主动脉内球囊反搏;心肌梗死;并发症;预后

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 宋莉,颜红兵,王健,赵汉军,李庆祥,吴铮,迟云鹏,李世英,徐方兴

参考文献(References)：

• [1]Antman EM,Anbe DT,Armstrong PW,et al.ACC/AHAguide-lines for the management of patients with ST-elevation myocardial infarction;a report of the American College of Cardiology/Ameri-can Heart Association Task Force on Practice Guidelines(Com-mittee to Revise the1999Guidelines for the Management of pa-tients with acute myocardial infarction).J Am Coll Cardiol,2004,44:e1-211.
• [2]Mahaffey KW,Kruse KR,Ohman EM.Perspectives on the use of intra-aortic balloon counterpulsation in the1990s//Topol EJ,editor.Textbook of Interventional Cardiology,Update Series,Update no.21.Philadelphia:PA:W.B.Saunders,1996:303-320.
• [3]Fotopoulos GD,Mason MJ,Walker S,et al.Stabilisation of medically refractory ventricular arrhythmias by intra-aortic balloon counterpulsation.Heart,1999,82:96-100.
• [4]Ferguson JJ3rd,Cohen M,Freedman RJ Jr,et al.The current practice of intra-aortic balloon counterpulsation:results from the Benchmark Registry.J Am Coll Cardiol,2001,38:1456-1462.
• [5]Cohen M,Urban P,Christenson JT,et al.Intra-aortic balloon counterpulsation in US and non-US centres:results of the Bench-mark Registry.Eur Heart J,2003,24:1763-1770.
• [6]Stone GW,Ohman EM,MillerM F,et al.Contemporary utiliza-tion and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction:the benchmark registry.J Am Coll Cardi-ol,2003,41:1940-1945.[7.]中华医学会心血管病学分会,中华心血管病杂志编辑委员会,中国循环杂志编辑委员会.急性心肌梗死诊断和治疗指南.中华心血管病杂志,2001,29:710-725.
• [8]Ohman EM,George BS,White CJ,et al.Use of aortic counter-pulsation to improve sustained coronary artery patency during a-cute myocardial infarction.Results of a randomized trial.The Randomized IABP Study Group.Circulation,1994,90:792-799.
• [9]Mishra S,Chu WW,Torguson R,et al.Role of prophylactic in-tra-aortic balloon pump in high-risk patients undergoing percuta-neous coronary intervention.Am J Cardiol,2006,98:608-612.
• [10]Stone GW,Marsalese D,Brodil BR,et al.A prospective,ran-domized evaluation of prophylactic intra aortic balloon counter pulsation in high risk patients with acute myocardial infarction treated with primary angioplasty.Second Primary Angioplasty in Myocardial Infarction(PAMI-II)Trial Investigators.J Am Coll Cardiol,1997,29:1459-1467.
• [11]Vijayalakshmi K,Kunadian B,Whittaker VJ,et al.Intra-aortic counterpulsation does not improve coronary flowearly after PCI in a high-risk group of patients:observations from a randomized trial to explore its mode of action.J Invasive Cardiol,2007,19:339-346.
• [12]Fasseas P,Cohen M,Kopistansky C et al.Pre-operative intra-aortic balloon counterpulsation in stable patients with left main coronary disease.J Invas Cardiol,2001,13:679-683.
• [13]Smith S C,Feldman T E,Hirshfeld J W,et al.ACC/AHA/SCAI2005guideline update for percutaneous coronary interven-tion:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(ACC/AHA/SCAI Writing Committee to Update2001Guidelines for Percutaneous Coronary Intervention).Circulation,2006,113:e166-286.
• [14]Flaherty JT,Becker LC,Weiss JL,et al.Results of a random-ized prospective trial of intra-aortic balloon counterpulsation and intravenous nitroglycerin in patients with acute myocardial infarc-tion.J Am Coll Cardiol,1985,6:434-446.